Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
FDA called for comments on its preliminary list of disease areas for study under FDA's patient-focused drug development initiative under the Prescription Drug User Fee Act.
United StatesFood, Drugs, Healthcare, Life Sciences
In the October 8, 2014,Federal Register, FDA called for comments on
its preliminary list of disease areas for study under FDA's
patient-focused drug development initiative under the Prescription
Drug User Fee Act ("PDUFA"). Comments due December 5,
2014.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
